Relación entre los niveles de interleucina 6 y depresión en pacientes afectados por Covid-19

Serrano García, Antonio; Montánchez Mateo, Judith; Franch Pato, Clara Margarita; Gómez Martínez, Rocío; García Vázquez, Paula; González Rodríguez, Isabel.
Med. clín (Ed. impr.) ; 156(7): 332-335, abril 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-208489

Documentos relacionados

  1. Living in the midst of fear: Depressive symptomatology among US adults during the COVID-19 pandemic.
  2. Therapeutic Interventions with Videogames in Treatments for Depression: A Systematic Review.
  3. [Clinical analysis of suspected COVID-19 patients with anxiety and depression].
  4. Correlation between immune response and self-reported depression during convalescence from COVID-19.
  5. Comparison of Prevalence and Associated Factors of Anxiety and Depression Among People Affected by versus People Unaffected by Quarantine During the COVID-19 Epidemic in Southwestern China.
  6. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.
  7. Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies
  8. Prevalence of depression during the SARS, MERS, and COVID-19 pandemics: A protocol for overview of systematic reviews.
  9. Changes in Psychological Distress During the COVID-19 Pandemic in Japan: A Longitudinal Study.
  10. Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance.